nd 630

Firsocostat (GS-0976) is an inhibitor of acetyl-CoA carboxylase (ACC) dimerization that inhibits human ACC1 and ACC2 activity (IC50s of 2.1 and 6.1 nM, respectively)

Compound 63012-03-3, with CAS No. 63012-03-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 63012-03-3 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 63089-56-5, with CAS No. 63089-56-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 63089-56-5 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

CPD2028 is an intermediate of ND630, a potent acetyl coenzyme A carboxylase (ACC) inhibitor.

Firsocostat S enantiomer is the less active S enantiomer of Firsocostat.

Firsocostat S enantiomer (ND-630 S enantiomer) is the less active S enantiomer of Firsocostat. Firsocostat is an acetyl-CoA carboxylase ( ACC ) inhibitor.